Coherus BioSciences Inc (NAS:CHRS)
$ 1.88 -0.03 (-1.57%) Market Cap: 215.68 Mil Enterprise Value: 440.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q2 2022 Coherus BioSciences Inc Earnings Call Transcript

Aug 04, 2022 / 09:00PM GMT
Release Date Price: $10.58 (+5.17%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q2 2022 Coherus BioScience, Inc. Earnings Conference Call. (Operator Instructions)

I would now like to turn the call over to Marek. Please go ahead.

Marek Ciszewski

Thank you, Mandeep. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier announcing our financial results for the second quarter of 2022. This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K.

Today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include, but are not limited to, our ability to launch multiple new products, our ability to generate sufficient sales to achieve revenue growth and profitability, our SG&A and R&D expense guidance, our projected market share, our 2026 top line projections, our projections about the market opportunities and our ability to advance our product candidates and successfully launch our products according to our projected time

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot